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Background: Epidural fibrosis (EF) is a common complication after laminectomy. Salvianolic acid B (Sal B) is a major
bioactive component of a traditional Chinese medical agent, Salvia miltiorrhiza, which has shown anti-inflammatory,
anti-fibrotic and anti-proliferative properties. The object of this study was to investigate the effect of Sal B on the
prevention of epidural fibrosis in laminectomy rats.
Methods: A controlled double-blinded study was conducted in sixty healthy adult Wistar rats that underwent
laminectomy at the L1-L2 levels. The rats were randomly divided into 3 groups of 20: (1) Sal B treatment group;
(2) Vehicle group; (3) Sham group (laminectomy without treatment). All rats were sacrificed 4 weeks post-operatively.
The extent of epidural fibrosis, fibroblast proliferation and the expression of vascular endothelial growth factor (VEGF)
and inflammatory factors were analyzed.
Results: The recovery of all rats was uneventful. In the laminectomy sites treated with Sal B, the dura mater showed no
adhesion. Collagen deposition was significantly lower in the Sal B group than the other two groups. In addition, both
fibroblast and inflammatory cell counting in the laminectomy sites treated with Sal B showed better grades than the
other two groups. The expression of VEGF and inflammatory factors in operative sites also suggested better results in
the Sal B group than the other two groups.
Conclusions: Sal B inhibits fibroblast proliferation, blood vessel regeneration, and inflammatory factor expression. Thus,
Sal B is able to prevent epidural scar adhesion in post-laminectomy rats.
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Failed back surgery syndrome (FBSS) is gaining attention
from both lumbar surgeons and lumbar laminectomy
patients. FBSS occurs in 8-40% of patients who undergo
lumbar disc surgery [1]. Recurrent persistent low back
pain and chronic nerve radicular are the main character-
istics for FBSS [2]. Epidural fibrosis (EF) is widely ac-
cepted to be the main contributor to FBSS [3-5].
EF, as a scar tissue adjacent to the dura mater following
lumbar laminectomy, can lead to extensive nerve roots
and dural mater adhesions. Therefore, EF could cause re-
striction of nerve root mobility, dural compression and
spinal canal stenosis [6].
Various attempts have been made to prevent EF, such
as topical application of immunosuppressive agents [7],* Correspondence: haotao2015@126.com
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unless otherwise stated.anti-inflammatory agents [8], calcium channel blockers
[6], animal collagen membranes [9], modified meticulous
surgery [10], and traditional Chinese medical agents,
such as pseudo-ginseng and Angelica sinensis [5,11]. Al-
though some of them have achieved moderate success in
animals, there is still no single agent or biomaterial that
has reached the success of clinic application.
Salvianolic acid B (Sal B), a major bioactive component
of the traditional Chinese medical agent, Salvia miltior-
rhiza, is widely accepted for use against cardiovascular dis-
eases [12]. Sal B is reported to exert anti-inflammatory
and neuroprotective effects both in vivo and in vitro
[13-15]. And with the advantages of little or no toxicity,
Sal B is also able to alleviate liver fibrosis [16]. However,
there have been no studies investigating the effects of Sal
B on preventing EF.
In the present study in laminectomized rats, we evaluated
the efficacy of Sal B in the prevention of EF. Specifically,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Primer sequences
TGF-β1 (148 bp) forward, 5′-GCCCTGCCCCTACATTTGG-3′
reverse, 5′-CTTGCGACCCACGTAGTAGACGAT-3′;
IL-6 (131 bp) forward, 5′-ACCCCAACTTCCAATGCTCT-3′
reverse, 5′-TGCCGAGTAGACCTCATAGTGACC-3′
GAPDH (169 bp) forward, 5′-TCACCACCATGGAGAAGGC-3′
reverse, 5′-GCTAAGCAGTTGGTGGTGCA-3′
Table 2 Grades of epidural scar adhesion in rats,
according to the Rydell standard
Group Grade
0 1 2 3
Sham 5 0 0 0
Vehicle 0 0 1 4
Sal B 4 1 0 0
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A total of sixty adult healthy male Wistar rats (mean
weight 250 g) were employed. The present research was
approved by Qingdao University Medical College Medical
Ethics Committee. In compliance with the principles of
International Laboratory Animal Care and with the
European Communities Council Directive (86/809 /EEC),
animals were housed in the local laboratory under the
conditions of 20 to 25°C room temperature, a 12 hour
light–dark cycle and clean food and water ad libitum
(Additional file 1). All efforts were made to minimize ani-
mal numbers and suffering. The rats were housed for 10
days to adjust them to the environment pre-operatively.
Animals were randomly divided into three groups (20 rats
in each group): 1) Sal B treatment group (Sal B 30 mg/kg,
diluted in saline); 2) Vehicle group (saline); 3) Sham group
(laminectomy without treatment).
Agents and antibodies
Sal B (purity > 98%) was purchased from the National
Institute for the Control of Pharmaceutical and Bio-
logical Products (Beijing, China). Cal-EX II solution for
decalcification and dehydration was purchased from
Thermo Fisher Scientific (Waltham, MA, USA). β-
Dimethylaminobenzaldehyde was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Reverse Transcriptase was
purchased from Promega (Madison MA, USA). Primary
antibody and secondary antibodies were purchased from
abcam (Cambridge, UK).
Surgery
The rat laminectomy model was created as previously
reported [4-7]. The surgery was performed under sterile
conditions with basic surgical tools. Anesthetization was
performed by intra-peritoneal injection of 10% chloral
hydrate (0.3 ml/100 g body weight). All the rats were
numbered individually after being restrained on a warm
pad in the prone position. The fur of each rat was
shaved around L1 and L2 and the exposed skin was ster-
ilized. After that L1-L2 total laminectomy was per-
formed with a micro-rongeur. Close attention was paid
not to traumatize the dura and the nerve roots. After
complete hemostasis with saline, the wound site was
surgically closed.
Salvianolic acid B administration
In the Sal B treatment group, salvianolic acid B (30 mg/kg,
diluted in saline) was administered intragastrically [17]. In
the Vehicle group, the same volume of saline was given inthe same way. In the Sham group, no special treatment
was performed post-laminectomy.
Macroscopic assessment of EF
Macroscopic assessment was performed four weeks
post-laminectomy. Five rats were randomly selected
from each group and anesthetized. Then, the surgical
sites were reopened. The epidural adhesion was evalu-
ated by assistants in a double-blinded manner based on
the Rydell classification [4] (grade 0 = epidural scar tis-
sue was not adherent to the dura mater; grade 1 = epi-
dural scar tissue was adherent to the dura mater, but
easily dissected; grade 2 = epidural scar tissue was adher-
ent to the dura mater, and it was difficult to dissect with-
out disrupting the dura matter; grade 3 = epidural scar
tissue was firmly adherent to the dura mater and could
not be dissected).
Determination of Hydroxyproline content (HPC) analysis
HPC analysis was performed according to a previous
studies four weeks post-operatively [6,7]. Six rats in each
group were selected. The scar tissue, approximately 5
mg wet weight, was collected around the laminectomy
site. The samples were rinsed, homogenized, centrifuged,
and hydrolyzed. One milliliter of hydroxyproline devel-
oper (β–dimethylaminobenzaldehyde solution) was added
to the samples and the standards. The absorbance at
550 nm was read with a spectrophotometer. HPC per
milligram of scar tissue was calculated.
Histological analysis
Histological analysis was performed four weeks post-
laminectomy on five rats in each group. The whole L1-
L2 vertebral column, including muscles and epidural
scar tissue, was harvested and fixed in 10% phosphate-
buffered formaldehyde solution. Decalcification and
Figure 1 Hydroxyproline content was evaluated. Hydroxyproline
levels are expressed as the mean ± standard deviation of
hygrotissue. The Sal B group showed the lowest hydroxyproline
level. *P < 0.05, compared with the other two groups.
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3 days. Five-micrometer axial sections of the laminec-
tomy site were cut and stained with hematoxylin-eosin
(H&E) and Masson’s trichrome.
The epidural scar adhesion was evaluated under the
light microscope (Olympus ix-71). The number of fibro-
blasts and inflammatory cells were calculated based on a
previous study [5]: grade 1, fewer than 100 fibroblasts/
inflammatory cells per × 400 field; grade 2, 100 to 150 fi-
broblasts/inflammatory cells per × 400 field; grade 3,
more than 150 fibroblasts/inflammatory cells per × 400
field. Three different counting areas were selected at the
middle and at the margins of the laminectomy sites. The
cells were counted and their mean was calculated.
To further quantify the density of blood vessels in each
scar tissue, the VEGF immunohistochemistry was per-
formed with the monoclonal anti-VEGF antibody, and the
density of VEGF was evaluated. The fields to be counted
for VEGF expression were chosen at 400× magnification
from well-labeled areas. Staining of VEGF was assessed
with a semi-quantitative grading system that reflected
the intensity of staining within 20 randomly chosenFigure 2 Masson’s trichrome staining for epidural adhesion in the lam
a: Loose scar tissues without adherence to the dura mater were seen in th
observed in the Vehicle and Sham groups. The magnification was 100×. SCblood vessels in each scar: (0) no staining; (1) weak stain-
ing; (2) moderate staining; and (3) strong staining. Each
scar was then given an overall modified H-score ((number
of vessels that scored 0) × 0 + (number of vessels that
scored 1) × 1 + (number of vessels that scored 2) × 2 +
(number of vessels that scored 3) × 3) [18,19].
Analysis of IL-6 and TGF-β1 concentrations
The mRNA analyses of IL-6 and TGF-β1 were per-
formed four weeks post-operatively. Six rats in each
group were selected. The scar tissues were collected
from the laminectomy sites, and the total RNA was ex-
tracted. The RNA (2 μg) was transcribed into cDNA
with AMV Reverse Transcriptase. Quantitative real-
time PCR (qPCR) was performed based on a previous
study using the Bio-Rad MYIQ2 (USA) [4]. Primers
used are shown in Table 1. GAPDH amplification was
employed as an internal control.
Statistical analysis
The statistical analysis was performed with SPSS 13.0
statistical package (SPSS Inc., Chicago, IL, USA). Data
are expressed as the mean ± standard deviation. Single-
factor analysis of variance (ANOVA) and the q-test were
applied to evaluate three independent samples. Statistical
significance was assumed at p < 0.05.Results
Macroscopic assessment of epidural scar adhesion
The recovery of all rats was uneventful. All rats showed
no sign of wound infection, neurological deficit or dis-
turbance of wound healing.
In the Sal B group, soft or weak fibrous adhesion was
observed. In the Vehicle and Sham groups, severe epi-
dural adhesions were seen. The dissection of epidural
scar tissue would have led to serious bleeding and the
risk of dura mater disruption or nerve root injury. It was
impossible to re-expose the dura mater completely. The
grades of epidural scar adhesion were evaluated accord-
ing to the Rydell standard (Table 2).inectomy sites treated with Sal B (a), Vehicle (b) or nothing (c).
e Sal B group. b, c: Dense scar tissues adhered to the dura mater were
= spinal cord, D = dura mater, EF = epidural fibrosis, L = laminectomy.
Figure 3 Effect of Sal B on vascular endothelial growth factor (VEGF). Immunohistochemistry for VEGF in epidural scar tissues treated with Sal B
(a), Vehicle (b) or nothing (c). As shown in statistical analysis (d), the density of VEGF in the Sal B group (a) was less than the other 2 groups. *P < 0.05
vs the Vehicle and the Sham group. The density of VEGF in the Vehicle group was similar to that of the Sham group. The magnification was 400 ×.
Table 3 Grades of fibroblast and inflammatory cell densities
Groups Fibroblast density Inflammatory cell density
Sal B
Sal B 1 1 1
Sal B 2 2 1
Sal B 3 1 1
Sal B 4 1 1
Sal B 5 1 2
Vehicle
Vehicle 1 3 3
Vehicle 2 3 2
Vehicle 3 3 3
Vehicle 4 3 3
Vehicle 5 3 3
Sham
Sham 1 3 3
Sham 2 3 3
Sham 3 3 3
Sham 4 3 3
Sham 5 3 3
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As shown in Figure 1, HPC concentration in epidural scar
tissue in the Sal B group (31.54 ± 5.06) was significant
lower than that in the Vehicle group (50.34 ± 4.19, P =
0.006) and the Sham group (53.59 ± 3.27,P = 0.001). The
content in Vehicle group showed no significant difference
compared with the Sham group (P = 0.249).
Histological analysis
In the Sal B group, loose or little epidural scar adhesion
was seen (Figure 2a). In the Vehicle group and the Sham
group, dense epidural scar tissue with widespread adhe-
sions to the dura mater was observed (Figure 2b,c). The
immunohistochemistry analysis for VEGF showed that
less VEGF was observable in the Sal B group versus the
Vehicle and Sham groups. Representative sections are
shown in Figure 3.
Effect of Sal B on fibroblasts and inflammatory cells
The fibroblasts and inflammatory density grades of epi-
dural scar tissue in each group are listed in Table 3. The
fibrotic and inflammatory cell densities in the Sal B
group were lower than those of the Vehicle group and
the Sham group. Both fibroblast and inflammatory cell
densities were similar between the Vehicle group and
the Sham group. Representative sections are shown in
Figure 4.
Effect of Sal B on IL-6 and TGF- β1
The mRNA expression levels of TGF-β1 and IL-6 are
shown in Figure 5. The Sal B group had significantly lowerexpression of both than the Vehicle group (P = 0.014) and
the Sham group (P = 0.005). The Vehicle group and Sham
group did not show a significant difference (P = 0.217).
Discussion
Usually, epidural fibrosis forms after laminectomy, and
discectomy leads to an unfavorable clinical outcome. It
Figure 4 H&E staining of fibroblasts in epidural scar tissues treated with Sal B (a), Vehicle (b) or nothing (c). The density of fibroblasts in
the Sal B group (a) was less than those of the other 2 groups. The density of fibroblasts in the Vehicle group (b) was similar to that of the Sham group (c).
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repair the local defect post-surgery. The fibroblast plays
an important role in the repair process [7]. After being
activated by inflammatory factors, it propagates and pro-
duces collagen fibers to act in a repairing role. However,
local excessive inflammatory and fibrotic processes will
cause excessive local collagen deposition. As a result, ex-
cessive scar tissue, transformed from fibrous connective
tissue, can easily squeeze the dura mater or nerve root.
Spinal stenosis, nerve root mobility restriction and dural
compression could result. Therefore, it is widely accepted
that EF is characterized by the accumulation of fibroblasts,
the deposition of extracellular matrix proteins, and the
distortion of normal tissue architecture with inflammation
[18]. To effectively curtail EF, it is important to reduce
these three factors [4].
In the present study, the potential ability of Sal B to
reduce epidural scar adhesion and inhibit fibrotic and in-
flammatory cell proliferation at laminectomy sites was
suggested. Multiple evaluations, including the Rydell
classification, histological analysis, hydroxyproline con-
tent, VEGF density grade and qPCR suggested Sal B
effectively prevents EF in laminectomized rats. The anti-Figure 5 mRNA expression of inflammatory factors (IL-6 and TGF-β1)
compared with the Sham group.fibrotic, anti-inflammatory, and anti-proliferative proper-
ties of Sal B have been used in different medical fields
[14,16,17]. The present study confirms its beneficial
properties in laminectomized rats. One effect of Sal B
that reduced fibrosis was its downregulation of IL-6 and
TGF-β1, which are suggested to play important roles in
the promotion and/or development of EF [4-7]. Previous
and current data may explain some if not all of the pos-
sible mechanisms that make Sal B effective in curtailing
EF [20-22]. We hypothesize that the mechanism by
which Sal B inhibits EF is its reduction of inflammatory
cytokines, fibroblast proliferation and collagen depos-
ition by blocking several signaling pathways, such as NF-
κB and ERK signaling [16,23,24].
Recently, different medication have been proved to play
curative effect on preventing EF. Immunosuppressive
agent, antineoplastic agent and antibiotics all supported a
good effectiveness on the prevention of EF [25-27]. To
avoid the complication from the high-dose agents and find
an optimal dose, we believe a combination between the
aforementioned agent and Sal B will be a good strategy.
More research will be performed. To our knowledge, this
is the first study to suggest that Sal B prevents EF byin epidural scar tissue from each group. Data from qPCR. *P < 0.05,
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droxyproline deposition in rats. In the present study in EF
rats, we did not attempt to define the most effective dose
or high-dose toxicity. Undoubtedly, more research on the
safety, long-term effects, safe effective concentration, and
possible side effects and adverse effects of Sal B are all
warranted before clinical trials and application.
Conclusions
Sal B can inhibit fibroblast proliferation, blood vessel re-
generation, and inflammatory factor expression. Thus,
Sal B is able to prevent epidural scar adhesion in post-
laminectomy rats.
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